Novavax COVID-19 vaccine shown highly effective in trial

Novavax on Monday revealed the results of a phase three COVID-19 vaccine trial that determined that the company’s two-dose inoculation is highly effective.The trial, in which 29,960 participants were enrolled across 119 states in the…